GlassScriptPhysician profile
William Gallagher
NPI 1295170082
$757.91
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.57 · 2020: $35.54 · 2021: $69.30 · 2022: $135 · 2023: $272 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $178.04 | 2019-2024 | Euflexxa |
| Djo, LLC | $133.98 | 2024 | Cmf |
| Depuy Synthes Sales INC. | $116.75 | 2022-2023 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $109.82 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Endo Pharmaceuticals INC. | $44.15 | 2021-2023 | Xiaflex |
| Orthofix Medical, INC. | $40.78 | 2021 | |
| Tersera Therapeutics LLC | $24.68 | 2019 | |
| Axogen | $22.48 | 2020 | |
| Medtronic, INC. | $22.27 | 2024 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $18.25 | 2023 | Evoke Scs |
| Pacira Therapeutics, INC. | $18.23 | 2019 | |
| Cerapedics INC. | $15.30 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.